Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 6Resectable Pancreatic Cancer 1Locally Advanced Pancreatic Adenocarcinoma 1Gastrointestinal Neoplasms 1Colonic Neoplasms 1

Interventions

Surveys and Questionnaires 2Standard of Care 2Radiosurgery 2Practice Guidelines as Topic 2Oxaliplatin 2Nivolumab 2Leucovorin 2Fluorouracil 2tislelizumab 1irinotecan sucrosofate 1folfirinox 1fludarabine 1encorafenib 1durvalumab 1canakinumab 1avatrombopag 1aldesleukin 1Transurethral Resection of Prostate 1Sodium Chloride 1Restraint, Physical 1Remote Patient Monitoring 1Radiotherapy 1Psilocybin 1Poly(ADP-ribose) Polymerase Inhibitors 1Panitumumab 1Observation 1Massage 1Magnetic Resonance Spectroscopy 1Levoleucovorin 1Irinotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Gastrointestinal Neoplasms × folfirinox × Clear all
NCT05121038 2024-12-17

CENDIFOX

University of Kansas Medical Center

Phase 1/2 Active not recruiting
50 enrolled
Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡